Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Carfilzomib	TA457 - Carfilzomib for previously treated multiple myeloma	For hospital use only
Carfilzomib (Kyprolis®)	TA657 - Carfilzomib for previously treated multiple myeloma TA695 - Carfilzomib with dexamethasone and lenalidomide for previously treated multiple myeloma
Carglumic acid		NHSE commissioned
Carglumic acid dispersible tablets		NHSE commissioned.
Carmustine 7.7mg implants	TA121 - Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma TA149 - Carmustine implants for the treatment of recurrent glioblastoma multiforme (terminated appraisal)	For hospital use only
Carmustine injection		For hospital use only
Catheter patency solution - sodium chloride
Ceftazidime nebulised		Hospital only
Cefuroxime 5% eye drops (preserv-free)		Unlicensed. Ophthalmologist only.
Cefuroxime 5% powder		Unlicensed. Ophthalmologist only.

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.